Katherine Stueland describes joining GeneDx as a first time CEO during a turbulent time and reshaping it into a leader in genetic testing for rare disease diagnosis

She describes how the mission of getting the company on stable ground through financial discipline and a sharper focus on strategy has enabled it to thrive and deliver on its mission for patients. Plus, her advice to others having gone through it as a first time CEO.